Evidence map›Paper›PMID 42324292›Full record

ArticleScientific reports2026

Early prediction of severe Omicron pneumonia using a multimodal a.i. model integrating delta CT radiomics and laboratory indicators.

Xiaoxian Ye, Xuhao Dai, Shengping Gong, Yingying Zhou, Ting Zhu, Binbin Song, Jiming Yang, Xiaoqin Ge, Jiangping Ren, Cong Shi and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoxian Ye *Department of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Xuhao Dai *Department of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Shengping Gong *Department of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Yingying ZhouDepartment of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Ting ZhuDepartment of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Binbin SongDepartment of Oncology, Affiliated Hospital of Jiaxing University, No. 1882, Zhonghuan South Road, Nanhu District, Jiaxing, 314000, Zhejiang, China.
Jiming YangDepartment of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Xiaoqin GeDepartment of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China.
Jiangping RenDepartment of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, China. fyyrenjiangping@nbu.edu.cn.
Cong ShiStem Cell Laboratory, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China. shicong5103@sina.com.
Yijian CaoDepartment of Oncology, Affiliated Hospital of Jiaxing University, No. 1882, Zhonghuan South Road, Nanhu District, Jiaxing, 314000, Zhejiang, China. caoyj22@tsinghua.org.cn.

Funding

the National Clinical Key Specialty Construction Project 2023-GJZK-001the Ningbo Public Welfare Science and Technology Program Project 2023S046the Zhejiang Medical and Health Science and Technology Project 2024KY328
6 · The paper itself

Abstract

Early identification of patients at risk of severe pneumonia during Omicron SARS-CoV-2 infection is critical for optimizing care and allocating resources. While clinical markers provide insights, imaging-derived radiomics features may enhance prognostic accuracy. We developed a multimodal predictive model combining Delta Radiomics features from serial chest CT scans with clinical data, including blood biochemical markers and lymphocyte subsets. The primary prediction target was severe/critical Omicron pneumonia during hospitalization. Mild and moderate cases were grouped as non-severe disease, whereas severe and critical cases were defined as the severe class for binary classification. The model was trained on 91 patients from the first center, internally validated on 23 patients, and externally tested on 32 patients from a second center. Machine learning algorithms including Logistic Regression, Random Forest, and MLP were applied, and a nomogram was constructed for individualized risk prediction. The combined model showed high discrimination in the training cohort and maintained favorable performance in the internal validation and independent external test cohorts, achieving AUCs of 0.885 and 0.875, respectively. The Delta Radiomics signature, particularly with MLP, showed comparatively stable predictive performance. These findings suggest the added value of temporal CT-derived radiomics when integrated with clinical biomarkers, although further validation in larger prospective cohorts is required. Integrating temporal imaging features with clinical data offers a non-invasive method for early prediction of severe/critical Omicron pneumonia, supporting individualized triage and more efficient allocation of medical resources.

Indexed as

COVID-19Tomography, X-Ray ComputedAgedBiomarkersFemaleHumansMachine LearningMaleMiddle AgedNomogramsPredictive Learning ModelsPrognosisRadiomicsSARS-CoV-2Severity of Illness IndexBiomarkersClinical biomarkersDelta radiomicsMachine learningNomogramOmicron COVID-19Prognostic risk stratification

Identifiers

PMID42324292
PMCPMC13562556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.